1. Ahlborg, H.G., Rosengren, B.E., Järvinen, T.L.N., Rogmark, C., Nilsson, J.-Å., Sernbo, I., and Karlsson, M.K. Prevalence of osteoporosis and incidence of hip fracture in women - secular trends over 30 years. BMC Musculoskelet Disord 11, 48, 2010.
2. Hernlund, E., Svedbom, A., Ivergard, M., Compston, J., Cooper, C., Stenmark, J., McCloskey, E.V., Jonsson, B., and Kanis, J.A. Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos 8, 136, 2013.
3. Braithwaite, R.S., Col, N.F., and Wong, J.B. Estimating hip fracture morbidity, mortality and costs. J Am Geriatr Soc 51, 364, 2003.
4. Salari Sharif, P., Abdollahi, M., and Larijani, B. Current, new and future treatments of osteoporosis. Rheumatol Int 31, 289, 2011.
5. Black , D.M., Delmas , P.D., Eastell , R., Reid , I.R., Boonen , S., Cauley , J.A., Cosman , F., Lakatos , P., Leung , P.C., Man , Z., Mautalen , C., Mesenbrink , P., Hu , H., Caminis , J., Tong , K., Rosario-Jansen , T., Krasnow , J., Hue , T.F., Sellmeyer , D., Eriksen , E.F., and Cummings , S.R. Once-Yearly Zoledronic Acid for Treatment of Postmenopausal Osteoporosis. New Eng J Med 356, 1809, 2007.
6. Lyles , K.W., Colón-Emeric , C.S., Magaziner , J.S., Adachi , J.D., Pieper , C.F., Mautalen , C., Hyldstrup , L., Recknor , C., Nordsletten , L., Moore , K.A., Lavecchia , C., Zhang , J., Mesenbrink , P., Hodgson , P.K., Abrams , K., Orloff , J.J., Horowitz , Z., Eriksen , E.F., and Boonen , S. Zoledronic Acid and Clinical Fractures and Mortality after Hip Fracture. New Eng J Med 357, 1799, 2007.
7. Coleman, R., Woodward, E., Brown, J., Cameron, D., Bell, R., Dodwell, D., Keane, M., Gil, M., Davies, C., Burkinshaw, R., Houston, S.J., Grieve, R.J., Barrett-Lee, P.J., and Thorpe, H. Safety of zoledronic acid and incidence of osteonecrosis of the jaw (ONJ) during adjuvant therapy in a randomised phase III trial (AZURE: BIG 01-04) for women with stage II/III breast cancer. Breast Cancer Res Treat 127, 429, 2011.
8. Kanis, J.A., Cooper, C., Rizzoli, R., Abrahamsen, B., Al-Daghri, N.M., Brandi, M.L., Cannata-Andia, J., Cortet, B., Dimai, H.P., Ferrari, S., Hadji, P., Harvey, N.C., Kraenzlin, M., Kurth, A., McCloskey, E., Minisola, S., Thomas, T., and Reginster, J.Y. Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting. Osteoporos Int 28, 2023, 2017.
9. Landfeldt, E., Ström, O., Robbins, S., and Borgström, F. Adherence to treatment of primary osteoporosis and its association to fractures—the Swedish Adherence Register Analysis (SARA). Osteoporos Int 23, 433, 2012.
10. Urist, M.R. Bone: Formation by Autoinduction. Science 150, 893, 1965.
11. Raina, D.B., Isaksson, H., Teotia, A.K., Lidgren, L., Tagil, M., and Kumar, A. Biocomposite macroporous cryogels as potential carrier scaffolds for bone active agents augmenting bone regeneration. J Control Release 235, 365, 2016.
12. Rodriguez-Evora, M., Delgado, A., Reyes, R., Hernandez-Daranas, A., Soriano, I., San Roman, J., and Evora, C. Osteogenic effect of local, long versus short term BMP-2 delivery from a novel SPU-PLGA-betaTCP concentric system in a critical size defect in rats. Our J Pharm Sci 49, 873, 2013.
13. Uludag, H., D'Augusta, D., Palmer, R., Timony, G., and Wozney, J. Characterisation of rhBMP-2 pharmacokinetics implanted with biomaterial carriers in the rat ectopic model. J Biomed Mater Res 46, 193, 1999.
14. Seeherman, H.J., Li, X.J., Bouxsein, M.L., and Wozney, J.M. rhBMP-2 induces transient bone resorption followed by bone formation in a nonhuman primate core-defect model. J Bone Joint Surg Am 92, 411, 2010.
15. Kaneko, H., Arakawa, T., Mano, H., Kaneda, T., Ogasawara, A., Nakagawa, M., Toyama, Y., Yabe, Y., Kumegawa, M., and Hakeda, Y. Direct stimulation of osteoclastic bone resorption by bone morphogenetic protein (BMP)-2 and expression of BMP receptors in mature osteoclasts. Bone 27, 479, 2000.
16. Raina, D.B., Isaksson, H., Hettwer, W., Kumar, A., Lidgren, L., and Tägil, M. A Biphasic Calcium Sulphate/Hydroxyapatite Carrier Containing Bone Morphogenic Protein-2 and Zoledronic Acid Generates Bone. Sci Rep 6 2016.
17. Mathavan, N., Bosemark, P., Isaksson, H., and Tagil, M. Investigating the synergistic efficacy of BMP-7 and zoledronate on bone allografts using an open rat osteotomy model. Bone 56, 440, 2013.
18. Kaczmarczyk, J., Sowinski, P., Goch, M., and Katulska, K. Complete twelve month bone remodeling with a bi-phasic injectable bone substitute in benign bone tumors: a prospective pilot study. BMC Musculoskelet Disord 16 2015.
19. Antonio, A., Mats, G., Philippe, K., and Magnus, T. Osteotomy of distal radius fracture malunion using a fast remodeling bone substitute consisting of calcium sulphate and calcium phosphate. J Biomed Mater Res B: Appl Biomater 92B, 281, 2010.
20. Wang, J.-S., Tägil, M., Isaksson, H., Boström, M., and Lidgren, L. Tissue reaction and material biodegradation of a calcium sulfate/apatite biphasic bone substitute in rat muscle. J Orthop Transl 6, 10, 2016.
21. Teotia, A.K., Gupta, A., Raina, D.B., Lidgren, L., and Kumar, A. Gelatin-Modified Bone Substitute with Bioactive Molecules Enhance Cellular Interactions and Bone Regeneration. ACS Appl Mater Interfaces 8, 10775, 2016.
22. Horstmann, P.F., Raina, D.B., Isaksson, H., Hettwer, W., Lidgren, L., Petersen, M.M., and Tagil, M. Composite Biomaterial as a Carrier for Bone-Active Substances for Metaphysical Tibial Bone Defect Reconstruction in Rats. Tissue Eng Part A 2017. http://doi.org/10.1089/ten.tea.2017.0040
23. Li, M., Shen, Y., and Wronski, T.J. Time course of femoral neck osteopenia in ovariectomized rats. Bone 20, 55, 1997.
24. Hessle, L., Stordalen, G.A., Wenglén, C., Petzold, C., Tanner, E.K., Brorson, S.-H., Baekkevold, E.S., Önnerfjord, P., Reinholt, F.P., and Heinegård, D. The Skeletal Phenotype of Chondroadherin Deficient Mice. PLoS ONE 8, e63080, 2013.
25. Boyd, S.K., Davison, P., Muller, R., and Gasser, J.A. Monitoring individual morphological changes over time in ovariectomized rats by in vivo micro-computed tomography. Bone 39, 854, 2006.
26. Mathavan, N., Turunen, M.J., Tagil, M., and Isaksson, H. Characterising bone material composition and structure in the ovariectomized (OVX) rat model of osteoporosis. Calcif Tissue Int 97, 134, 2015.
27. Seeherman, H.J., Li, X.J., Smith, E., Parkington, J., Li, R., and Wozney, J.M. Intraosseous injection of rhBMP-2/calcium phosphate matrix improves bone structure and strength in the proximal aspect of the femur in chronic ovariectomized nonhuman primates. J Bone Joint Surg Am 95, 36, 2013.
28. Li, M., Liu, X., Liu, X., and Ge, B. Calcium Phosphate Cement with BMP-2-loaded Gelatin Microspheres Enhances Bone Healing in Osteoporosis: A Pilot Study. Clin Orthop Rel Res 468, 1978, 2010.
29. Mathavan, N., Tagil, M., and Isaksson, H. Do osteoporotic fractures constitute a greater recalcitrant challenge for skeletal regeneration? Investigating the efficacy of BMP-7 and zoledronate treatment of diaphyseal fractures in an open fracture osteoporotic rat model. Osteoporos Int 28, 697, 2017.
30. Gao, Y., Zou, S., Liu, X., Bao, C., and Hu, J. The effect of surface immobilised bisphosphonates on the fixation of hydroxyapatite-coated titanium implants in ovariectomized rats. Biomaterials 30, 1790, 2009.
31. von Knoch, F., Jaquiery, C., Kowalsky, M., Schaeren, S., Alabre, C., Martin, I., Rubash, H.E., and Shanbhag, A.S. Effects of bisphosphonates on proliferation and osteoblast differentiation of human bone marrow stromal cells. Biomaterials 26, 6941, 2005.
32. Chang, J.U.N., Wang, W.E.I., Zhang, H.U.I., Hu, Y., and Yin, Z. Bisphosphonates regulate cell proliferation, apoptosis and pro-osteoclastic expression in MG-63 human osteosarcoma cells. Oncol Lett 4, 299, 2012.
33. Murphy, C.M., Schindeler, A., Gleeson, J.P., Yu, N.Y., Cantrill, L.C., Mikulec, K., Peacock, L., O'Brien, F.J., and Little, D.G. A collagen-hydroxyapatite scaffold allows for binding and co-delivery of recombinant bone morphogenetic proteins and bisphosphonates. Acts Biomater 10, 2250, 2014.
34. Holzer, G., von Skrbensky, G., Holzer, L.A., and Pichl, W. Hip fractures and the contribution of cortical versus trabecular bone to femoral neck strength. J Bone Miner Res 24, 468, 2009.
35. Flecknell, P. Replacement, reduction and refinement. Altex 19, 73, 2002.
36. Maimoun, L., Brennan-Speranza, T.C., Rizzoli, R., and Ammann, P. Effects of ovariectomy on the changes in microarchitecture and material level properties in response to hind leg disuse in female rats. Bone 51, 586, 2012.
37. Asumda, F.Z., and Chase, P.B. Age-related changes in rat bone-marrow mesenchymal stem cell plasticity. BMC Cell Biol 12, 44, 2011.
38. Raina, D.B., Isaksson, H., Tägil, M., and Lidgren, L. Ceramic biomaterial functionalized with bone morphogenic protein-2 and zoledronic acid: evaluating release kinetics in vivo. Orthop Proc 100-B, 46, 2018.